July 12, 2022 — Pesticides and heavy metals in soil may have detrimental effects on the cardiovascular system, according to a review paper published today in Cardiovascular Research, a journal of the European Society of Cardiology (ESC).1  

July 11, 2022 — BioSig Technologies, Inc., a medical technology company advancing electrophysiology workflow by delivering greater intracardiac signal fidelity through its proprietary signal processing platform, today announced that Kansas City Heart Institute at Overland Park Regional Medical Center in Kansas City, U.S. has signed a purchase agreement to acquire its PURE EP(T.M.) System.  

July 11, 2022 — Rod was diagnosed with cancer, but it wasn’t his most urgent medical issue. 

A few months after that diagnosis, and with his heart rate “going berserk,” according to his daughter, Rebecca, Rod was taken to the emergency room. There it was discovered he had an arrythmia, but even that wasn’t his biggest problem. 

July 11, 2022 — Smoking traditional or non-combustible cigarettes while wearing a surgical mask results in a two-fold rise in exhaled carbon monoxide and impaired blood vessel function compared to non-mask periods.

July 11, 2022 – The American Society of Nuclear Cardiology (ASNC) and the Society of Nuclear Medicine and Molecular Imaging (SNMMI) have reported a significant advocacy victory. In updates issued June 27, 2022, each reported that Aetna has reversed its policy of non-coverage for cardiac PET/CT.

July 8, 2022 — The Society of Cardiovascular Computed Tomography (SCCT) has released a new expert consensus document on Coronary Artery Disease – Reporting and Data System (CAD-RADS) in collaboration with the American College of Cardiology (

July 7, 2022 —  Telemedicine has expanded rapidly since the beginning of the pandemic and is being increasingly adopted in the medical world to treat neurological, respiratory and cardiovascular diseases, says GlobalData, a lea

July 7, 2022 — Tenaya Therapeutics, Inc., a biotechnology company with a mission to discover, develop and deliver curative therapies that address the underlying causes of heart disease, announced the publication of preclinical research in the July 6 issue of 

July 7, 2022 — A 5-year, $3.1 million grant from the National Heart, Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), will enable researchers from Atrium Health Wake Forest Baptist’s NCI-designated Comprehensive Cancer Center, Virginia Commonwealth University Massey Cancer Center and Duke Cancer Institute to collaborate in a first-of-its-kind prospective study to look for the earliest signs of 

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now